Summary:
The UCLA Geriatric Psychiatry Program is conducting a 12-montth research sttudy on
the experimental drug combination for the treatment of depression. All participants
will be given tthe study drug Lexapro® (escitalopram) and Namenda® (memantine)
together or will be given Lexapro® with a placebo (an inactive substance).
Qualified Participants Must:
• Be atleast 60 years of age
Qualified Participants May Receive:
A complete psychiatric evaluation, a PET scan, and two MRI scans will be provided.